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INTRODUCTION
Since first lung transplantation (LTx) was performed in 1963 
by James Hardy of the University of Mississippi in 1963, there 
has been significant progress in the surgical techniques and 
medical support used in this field. However, the median sur-
vival of LTx recipients is about 5.5 years, which is still disap-
pointing compared to that of recipients of other solid organs.1 
Following morbidity and mortality from infections, account-
ing for approximately 35% of deaths in the first year of LTx,2 
airway complications are another major cause that deterio-
rates clinical outcomes of LTx recipients. The incidence of air-
way complications ranges broadly from 1.6% to 33% depending 
on the reporting system.3 In a large scale study, 18% of patients 
developed at least one anastomotic airway complication.4 
In the early era of LTx, disruption of the airway anastomosis 
was one of major causes of death among patients who survived 
at least 2 weeks after transplantation. The procedure of LTx 
and the transplanted lung create a unique environment that is 
prone to anastomotic airway complications. In addition to the 
fact that the donor organ is devascularized and systemic arte-
rial blood supply is not routinely connected, there are several 
unique factors that precipitate anastomotic airway complica-
tions, such as contamination of bronchial anastomoses fields, 
tension at the anastomosis site, and mismatched donor and re-
cipient organ sizes.5,6
Anastomotic airway complications after LTx are classified 
Anastomotic Airway Complications after Lung 
Transplantation
Eun Na Cho1, Suk Jin Haam2, Song Yee Kim1, Yoon Soo Chang1, and Hyo Chae Paik2
Departments of 1Internal Medicine and 2Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea.
Purpose: Anastomotic airway complications are a major cause of morbidity and mortality after lung transplantation (LTx). In this 
study, the authors identified types and clinical outcomes of airway complications after LTx. 
Materials and Methods: All bronchial anastomotic complications were analyzed in a total of 94 LTx cases involving 90 recipients 
who underwent surgery between July 2006 and May 2014. Fifteen LTx cases (14 recipients) with incomplete medical records for 
fiberoptic bronchoscopy (FBS) and three cases underwent heart-lung transplantation (HLT) were excluded. Postoperative FBS at 
24–48 hours, 1, 3, 6, and 12 months, and then yearly after the transplantation were performed.
Results: A total of 76 LTx cases (75 recipients) were analyzed. The mean age of the recipients was 49.55 years (range, 18–71 years), 
and 38 (49.4%) were male. Twenty-one out of 76 cases (27.6%) experienced early anastomotic complications, and 12 (15.8%) pre-
sented late anastomotic complications. The early anastomotic airway complications presented in various forms: stenosis, 1 case; 
narrowing, 1; necrosis & dehiscence, 3; fistula, 4; granulation, 10; and infection, 2. Late complications almost entirely presented in 
the form of bronchial stenosis; five recipients showed stenosis at the anastomosis site, and one of them showed improvement af-
ter ballooning. Five others were found to have stenosis at the bronchus intermedius, distal to the anastomosis site. Three of these 
patients showed improvement after ballooning or bronchoplasty.
Conclusion: By serial surveillance via FBS after LTx, we detected anastomotic airway complications in 42.9% of cases, which were 
successfully managed with improved clinical outcomes.
Key Words:  Lung transplantation, postoperative complications, surgical anastomosis
Yonsei Med J 2015 Sep;56(5):1372-1378
http://dx.doi.org/10.3349/ymj.2015.56.5.1372
Original Article 
pISSN: 0513-5796 · eISSN: 1976-2437
Received: August 5, 2014   Revised: October 29, 2014
Accepted: December 2, 2014
Corresponding author: Dr. Hyo Chae Paik, Department of Thoracic and Cardio-
vascular Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae-
mun-gu, Seoul 120-752, Korea.
Tel: 82-2-2228-2145, Fax: 82-2-393-6012, E-mail: hcpaik@yuhs.ac
•The authors have no financial conflicts of interest.
© Copyright: Yonsei University College of Medicine 2015
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/
by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
1373http://dx.doi.org/10.3349/ymj.2015.56.5.1372
Eun Na Cho, et al.
according to either the time of development or the nature of 
structural deformities. Airway complications that develop with-
in 3 months after surgery are designated as early complica-
tions whereas those after 3 months are late complications. 
Structural deformities at the bronchial anastomosis are classi-
fied as follows: stenosis, necrosis and dehiscence, exophytic 
granulation, bronchial malacia, fistula, and infection of the 
anastomosis.4,5 In the early era of LTx, bronchial complications 
such as dehiscence and necrosis were frequent causes of air-
way complications; these are classified as early complications.7 
In recent years, the incidence of airway complications has de-
creased as a result of the improvement of surgical techniques 
and changes in presentation at the time of diagnosis.6 In a re-
cent report by Santacruz and Mehta,3 necrosis and dehiscence 
was found to occur mainly in the early phase, while stenosis 
occurred mainly in the late phase. The incidence of early com-
plications has been gradually declining, whereas the relative in-
cidence of late complications, such as stenosis, has been in-
creasing.
In this study, we reviewed anastomotic complications after 
LTx and classified them according to time of development. We 
also investigated underlying causes using the pathologic diag-
nosis, identifiable risks, procedures to overcome each compli-
cation, clinical outcome, and natural course of the morbidity. 
Identification of risk factors and better understanding of the 
natural course of anastomotic airway complications after LTx 
may lead to better clinical outcomes of recipients. 
MATERIALS AND METHODS
From July 1996, a total of 94 LTx cases in 90 recipients were per-
formed as of May 2014 at Yonsei University Hospital. Of these 
cases, 15 (in 14 recipients) did not receive postoperative sur-
veillance fiberoptic bronchoscopy (FBS) or had incomplete 
FBS medical reports, and three cases (three recipients) that 
involved heart-lung transplantation (HLT) were not analyzed 
in this study. 
Demographic characteristics, primary lung diseases, micro-
biologic tests before and after transplantation, serial FBS, pul-
monary function tests, and episodes of infection throughout 
the post-transplantation observation period were reviewed. 
This study was reviewed and approved by the Institutional Re-
view Board at Gangnam Severance Hospital, Yonsei Universi-
ty College of Medicine (IRB No. #3-2012-0250).
Pre-op screening, antimicrobial prophylaxis, and 
immunosuppressive therapy
Before transplantation, sputum and bronchoalveolar lavage 
fluids from recipients were collected, cultured, and analyzed 
for bacteria and fungus. Serologic tests for cytomegalovirus 
(CMV), Epstein-Barr virus, hepatitis A, B, and C, herpes virus, 
and human immunodeficiency virus were also included. An-
timicrobial prophylaxis was based on the antibiotic sensitivity 
from the sputum culture of recipients and from the bronchial 
aspiration of donors. In patients whose colonization reports 
and antibiotic sensitivity were not available, a single agent, 
piperacillin-tazobactam, or a combination of ceftriaxone, ise-
pamicin, and metronidazole were administered. Every patient 
underwent prophylaxis for fungal infection with fluconazole for 
one year and for Pneumocystis jirovecii (P. jirovecii) infection 
with sulfamethoxazole-trimethoprim. Patients with moderate 
or high risk for CMV infection, such as recipient (+)/donor (+ or 
-), and recipient (-)/donor (+), respectively, received prophy-
lactic intravenous ganciclovir for two weeks, followed by oral 
valganciclovir for 6 months or up to one year. To induce immu-
nosuppression, methylprednisolone was used followed by 
maintenance with steroids, calcineurin inhibitor, and anti-me-
Fig. 1. Diagram of the study cases. Since July 1996, a total 90 patients (94 LTx cases) underwent LTx. Among 90 recipients, 18 LTx cases were exclud-
ed from this analysis. Among 76 LTx cases (75 recipients), 21 recipients showed early anastomotic complications and 12 late complications. LTx, lung 
transplantation; FOB, fiberoptic bronchoscopy; PFT, pulmonary function test.  
Patients received LTx between 
July 1996–May 2014, n=90 (LTx cases=94)
Patients followed with FOB and PFT, 
n=75 (LTx cases=76)
Patients do not receive postop surveillance 
FOB or no medical records of the FOB,
n=14 (LTx cases=15)
Patients underwent heart-lung transplantation (HLT),
n=3 (LTx cases=3)
Early complication,
n=21 (LTx cases=21)
No airway complication, 
n=43 (LTx cases=44)
Late complication,
n=12 (LTx cases=12)
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tabolites. Immunosuppression was maintained using medica-
tions consisting of prednisone, tacrolimus, and mycopheno-
late mofetil.
Post-transplant surveillance
Post-transplantation evaluation included pulmonary function 
tests, chest imaging studies, sputum bacterial cultures, FBS, 
and CMV antigenemia testing. Postoperative FBS was per-
formed at 24–48 hours, 1, 3, 6, and 12 months, and yearly after 
transplantation. For the evaluation of early and late airway 
complications, we diagnosed stenosis by visual assessment. 
Pulmonary function tests were performed at 1, 3, 6, and 12 
months and yearly after transplantation. If respiratory infec-
tion or rejection was suspected, the patient underwent a chest 
CT scan, fibrobronchoscopy with alveolar lavage for bacterial 
and fungal cultures, indirect immunofluorescence tests for vi-
ral and P. jirovecii infections, mycobacterial polymerase chain 
reaction, and transbronchial biopsies. 
Statistical analysis
The one-way analysis of variance (ANOVA) was used for uni-
variate analysis of continuous variables, and the χ2-test was 
used for analysis of categorical variables. All statistical analy-
ses were two-sided.
RESULTS
Characteristics of LTx recipients
A total of 94 LTx in 90 recipients who underwent surgery be-
tween July 2006 and May 2014 were collected, and 76 LTx cas-
es (75 recipients) who had no identifiable problems during this 
time period underwent further analysis (Fig. 1). The mean age 
of recipients was 49.55 years (range, 18–71 years), and 38 (49. 
4%) were male. Seven out of 76 underwent single LTx, and the 
remaining 69 cases were bilateral LTx. Twenty-four out of 76 
(31.6%) were diagnosed as chronic obstructive pulmonary dis-
ease (COPD) using a pre-operative pulmonary function test. 
As LTx recipients showed obstructive patterns of flow-volume 
loop, indicating variant underlying causes such as bronchiec-
tasis (non-cystic fibrosis), interstitial pulmonary fibrosis (IPF), 
or lymphangioleiomyomatosis (LAM), we classified subjects by 
pathological diagnosis. IPF was the leading cause of LTx, ac-
counting for 36 cases, followed by LAM (13 cases), bronchiec-
tasis (non-cystic fibrosis; eight cases), diffuse alveolar damage 
(four cases), diffuse panbronchiolitis (two cases), Eisenmenger 
syndrome (one case), interstitial lung disease related to con-
nective tissue disease (four cases), bronchiolitis obliterance 
(BO) after bone marrow transplantation (BMT; five cases), 
and three other cases (Table 1). Twenty-one out of 76 recipi-
ents (27. 6%) experienced early anastomotic airway complica-
tions and 12 (15.8%) experienced late complications. Forty-four 
LTx cases (43 recipients) did not show complications at anas-
tomosis sites during the follow-up period. In comparing recip-
ients who suffered airway complications with those who did 
not, there were no statistical differences in age, gender, or ra-
tio of donor-recipient total lung capacity. Recipients who suf-
fered from IPF or bronchiectasis (non-cystic fibrosis) experi-
enced airway complications more frequently than other 
disease subgroups. Among 33 LTx cases with anastomotic air-
way complications, one recipient with dehiscence died as a 
result of anastomotic airway complications. 
Table 1. Demographic Characteristics of the Study Participants
No complication
(n=44)
Early complication
(n=21)
Late complication
(n=12)
p value
Age (mean±SD) 49.43±12.72 49.52±13.31 50.00±14.44 0.858*
Gender 0.270†
Male 19 (50.0%) 13 (34.2%) 6 (15.8%)
Female 25 (65.8%) 7 (18.4%) 6 (15.8%)
Disease leading to transplant 0.954‡
Idiopathic pulmonary fibrosis 20 (54.1%) 10 (29.7%) 6 (16.2%)
Lymphangioleiomyomatosis 7 (53.8%) 3 (23.1%) 3 (23.1%)
Bronchiectasis 6 (75.0%) 1 (12.5%) 1 (12.5%)
Diffuse alveolar damage 3 (75.0%) 1 (25.0%) 0 (0.0%)
Diffuse panbronchiolitis 2 (100.0%) 0 (0.0%) 0 (0.0%)
Eisenmenger syndrome 0 (0.0%) 1 (100.0%)  0 (0%)
ILD related with connective tissue disease 3 (75.0%) 1 (25.0%)  0 (0%)
BO after BMT 3 (60.0%) 0 (0.0%) 2 (40.0%)
Other 0 (0.0%) 3 (100.0%) 0 (0.0%)
Ratio of TLC (donor/recipient) (mean±SD) 1.08±0.229 1.00±0.237 1.11±0.150  
SD, standard deviation; ILD, interstitial lung disease; BO after BMT, bronchiolitis obliterance after bone marrow transplantation; TLC, total lung capacity.
*p value was obtained from one-way analysis of variance (ANOVA), †p value was obtained from chi-square test, ‡p value was obtained from linear by linear as-
sociation. 
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Early anastomotic airway complications after LTx
Early anastomotic airway complications were defined as com-
plications that developed within 3 months of LTx. Among 76 
LTx recipients, 21 experienced early anastomotic airway com-
plications, and the median time of detection for these compli-
cations was 26 days after transplantation. Early anastomotic 
complications presented in various forms: stenosis (one case), 
narrowing (one case), necrosis & dehiscence (three cases), fis-
tula (four cases), granulation (ten cases), and infection (two 
cases) (Table 2). Stenosis was diagnosed by visual estimation. 
Five recipients, who experienced granulation and necrosis at 
anastomosis sites, respectively showed improvement with an-
tibiotics and antiviral agents without endoscopic intervention. 
However, other forms of early anastomotic airway complica-
tions such as fistula, stenosis, and dehiscence required specif-
ic interventions. All four recipients who presented with a fis-
tula 10–38 detection days after LTx underwent re-suture or 
surgical repair, and three patients showed improvement on 
follow-up bronchoscopy. One recipient with a fistula that had 
developed at the proximal portion of the right upper lobe 
bronchus at postoperative day (POD) #12 underwent emer-
gency open thoracotomy and surgical re-suture. After the re-
suture, follow-up bronchoscopy revealed stenosis of the right 
upper lobe bronchus (Fig. 2A). Fungal infection at anastomosis 
sites was another form of early airway complication. Bronchos-
copy, performed on an LTx recipient who experienced gradu-
ally aggravating dyspnea and rhonchi, revealed luminal nar-
rowing with exophytic granulation tissues at both anastomosis 
sites. A biopsy was performed at the granulation and con-
firmed Aspergillus fumigatus infection. After treatment with 
antifungal agents, the granulation sites healed, and minimal 
stenosis developed as a sequela on a follow-up study after 2 
months (Fig. 2B). Dehiscence at the anastomosis site was one 
of the most disastrous complications that developed without 
prodromal symptoms. One recipient experienced sudden and 
rapid clinical deterioration with shock. Emergency bronchos-
copy was performed and dehiscence at both anastomosis 
sites was identified. Despite intensive medical care, the recipi-
ent died before surgical intervention was initiated.
Late anastomotic airway complications after LTx
Late anastomotic airway complications were defined as those 
developing at least 3 months after LTx, and most of them pre-
sented in the form of stenosis. Twelve recipients experienced 
Fig. 2. Representative photographs of early anastomotic airway complications. (A) A case of early airway complication presenting fistula at anasto-
mosis site. No specific findings at the anastomosis site were detected by immediate post-op bronchoscope. At POD#12, fistula at the proximal portion 
of the right upper lobe bronchus was detected and re-suture was performed. Follow-up bronchoscope performed at POD#90 revealed stenosis of 
right upper lobe bronchus. (B) Another case of early airway complication showing fungal infection at anastomotic sites. Exophytic granulation tissues 
with 30% luminal narrowing at both anastomosis sites were identified at POD#18. Bronchoscopic biopsy and culture study revealed the granulation 
from A. fumigatus infection. After treatment with antifungal agents, the granulations were disappeared but there were minimal stenosis on a follow-
up study at POD#60. POD, postoperative day. 
POD#1
POD#18
POD#12
POD#32
POD#90
POD#60
A
B
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late anastomotic airway complications, and the median time 
of airway complication was 179 days after LTx. Five recipients 
showed stenosis at anastomosis sites, and four presented ste-
nosis at the bronchus intermedius, distal to the anastomosis 
site. One recipient diagnosed with BO after BMT presented fo-
cal stenosis at the right middle lobe. Among the nine recipients 
who showed stenosis at the right main bronchus (two cases), 
left main bronchus (two cases), both main bronchi (one case), 
and right bronchus intermedius (four cases), five recipients 
underwent balloon dilatation, and one recipient underwent 
surgical bronchoplasty (Table 3). Three out of five recipients 
who underwent bronchoscopic balloon dilatation showed 
improvement of airway stenosis. One patient who developed 
vanishing bronchus intermedius syndrome 295 days after LTx 
underwent surgical bronchoplasty, and the stenosis subse-
quently improved. Most cases required either surgical bron-
choplasty or ballooning, except for one case that presented with 
stenosis at the left main bronchus and one case that presented 
with focal stenosis at the right middle lobe bronchus and was 
diagnosed with BO after BMT, which showed improvement 
without intervention. These two cases were treated only with 
antibiotics and antifungal agents in order to treat other forms 
of infection such as infectious colitis and pneumonia. 
Among all LTx cases that presented with airway complica-
tions, only one case presented early airway complications in 
the form of fungal infection (case No. 6 in Table 2), and anoth-
er single case that presented with persistent stenosis of both 
main bronchi and was classified as a late complication (case 
No. 32 in Table 3) was successfully treated with ballooning.
DISCUSSION
In the early era of LTx, anastomotic airway complications were 
one of the major factors that determined the clinical outcomes 
of LTx recipients.6 With risk-factor identification and the ad-
vancement of surgical techniques, the frequency and aspect 
of anastomotic airway complications has changed. 
The prevalence of anastomotic airway complications varies 
widely depending on the reporting system. If all patents with 
abnormal findings by routine bronchoscopy were reported 
regardless of the need of intervention and associated symp-
toms, the prevalence of anastomotic airway complications is 
high, reaching up to 33%. On the other hand, if the reporting 
system counts only airway complications that are associated 
with symptoms, the prevalence of anastomotic complications 
is relatively low.5 Murthy, et al.4 indicated that only two thirds 
of patients with anastomotic complications have associated 
airway symptoms. In this study, the prevalence of anastomot-
ic complications was 39.0%, due to serial routine bronchosco-
py and an inclusive reporting system that counted cases with 
abnormal bronchoscopy findings regardless airway symp-
toms and intervention need. Ta
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   Anastomotic Airway Complications after LTx
Moreno, et al.6 reported that the risk factors for anastomotic 
complications include double LTx, post-transplantation airway 
colonization, and post-transplant intubation longer than 72 
hours. In this study, stenosis was a frequent sequela after early 
complications, such as fistula and infection. Aside from a small 
number of cases, anastomotic complications occurred belat-
edly in the late complication group, which had no identifiable 
findings on serial bronchoscopy until at least 3 months after 
LTx, consequently making it difficult to identify the risk factors 
for anastomotic complications in this study. One patient with 
early anastomotic complications died, while the rests survived 
during the time of analysis. Anastomotic airway complications 
palliate several months after LTx; however, they influence the 
prognosis and late death of recipients.4 Furthermore, inter-
ventions on the complicated airway perpetuate and further 
deteriorate the condition, indicating a strong need of early 
identification in order to avoid the risks.5
Despite anastomotic airway complications, the majority of 
patients were able to maintain their lung function parameters 
over time. When the effect of anastomotic complications on 
the parameters from the pulmonary function test were inves-
tigated by serial-FEV1/preoperative-FEV1, there was no sta-
tistical difference in the change of lung function between pre-
stenosis FEV1 and post-stenosis FEV1 when comparing those 
treated with ballooning or bronchoplasty, indicating that early 
and late anastomotic complications do not induce permanent 
deterioration of pulmonary lung function when proper inter-
vention is provided (data not shown). The incidence of BO was 
two out of 32 recipients with anastomotic complications and 
three of out 50 without anastomotic complications, suggest-
ing that BO might not be related to such complications. 
In conclusion, the incidence of anastomotic airway compli-
cations was 39.0% based on routine serial bronchoscopy per-
formed on LTx recipients who did not show postoperative com-
plications. The complications were successfully managed by 
either surgical or endoscopic means and did not worsen the 
clinical outcomes of the LTx recipients. 
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